All persons or entities that purchased or otherwise acquired Stemline Therapeutics, Inc. (“Stemline” or the “Company”) common stock during the period from January 20, 2017 to February 1, 2017, both dates inclusive
Disbursed
January 19, 2017 - May 02, 2017
September 23, 2019
September 02, 2019
Strategic Claims Services
Stemline Therapeutics, Inc. Securities Litigation
c/o Strategic Claims Services
P.O. Box 230
600 N. Jackson St., Ste. 205
Media, PA 19063
+1 440-04_-____
info@strategicclaims.net
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.